Company
SimBioSys
Chicago AI and biophysical-simulation company spun out of the University of Illinois Urbana-Champaign in 2018; TumorSight Risk is its fourth FDA 510(k) clearance.
2 stories
Regulatory News has published 2 stories about SimBioSys between 18 October 2026 and 21 October 2026, each sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 21 October 2026.
This page is generated from Regulatory News’ editorial coverage of SimBioSys. It is not an advertisement.
On the record
- Company
- SimBioSys, Inc.
- Headquarters
- Chicago, Illinois
- Founded
- 2018, spun out of the University of Illinois Urbana-Champaign’s EnterpriseWorks incubator
- Regulator
- U.S. Food and Drug Administration (CDRH)
- Latest milestone
- FDA 510(k) clearance, TumorSight Risk
Each line is taken from the most recent story of ours that states it.
